Effects of leuprolide in the treatment of central precocious puberty

Peter A. Lee, John G. Page

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Leuprolide acetate (d-Leu6 des-Gly-NH210, Pro-ethylamide9), a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone, was used to treat 62 children with central precocious puberty. Sex steroid levels (testosterone in boys and estradiol in girls) were suppressed during treatment lasting from 3.5 to 24.9 months. Basal follicle-stimulating hormone values and both luteinizing hormone and follicle-stimulating hormone peak responses to stimulation by luteinizing hormone releasing hormone were also suppressed, atthough basal luteinizing hormone values did not differ. Linear growth rate and the rate of bone age advancement decreased during leuprolide therapy. Side effects were minimal. The long-term safety of this treatment has not yet been established; however, leuprolide appears to be an effective long-term therapy for central precocious puberty.

Original languageEnglish (US)
Pages (from-to)321-324
Number of pages4
JournalThe Journal of Pediatrics
Volume114
Issue number2
DOIs
StatePublished - Feb 1989

Fingerprint

Leuprolide
Follicle Stimulating Hormone
Luteinizing Hormone
Gonadotropin-Releasing Hormone
Therapeutics
Testosterone
Estradiol
Steroids
Safety
Bone and Bones
Central Precocious Puberty
Growth

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{dc4943e4cdda43b6a9d0f54890c4c32b,
title = "Effects of leuprolide in the treatment of central precocious puberty",
abstract = "Leuprolide acetate (d-Leu6 des-Gly-NH210, Pro-ethylamide9), a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone, was used to treat 62 children with central precocious puberty. Sex steroid levels (testosterone in boys and estradiol in girls) were suppressed during treatment lasting from 3.5 to 24.9 months. Basal follicle-stimulating hormone values and both luteinizing hormone and follicle-stimulating hormone peak responses to stimulation by luteinizing hormone releasing hormone were also suppressed, atthough basal luteinizing hormone values did not differ. Linear growth rate and the rate of bone age advancement decreased during leuprolide therapy. Side effects were minimal. The long-term safety of this treatment has not yet been established; however, leuprolide appears to be an effective long-term therapy for central precocious puberty.",
author = "Lee, {Peter A.} and Page, {John G.}",
year = "1989",
month = "2",
doi = "10.1016/S0022-3476(89)80806-6",
language = "English (US)",
volume = "114",
pages = "321--324",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "2",

}

Effects of leuprolide in the treatment of central precocious puberty. / Lee, Peter A.; Page, John G.

In: The Journal of Pediatrics, Vol. 114, No. 2, 02.1989, p. 321-324.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of leuprolide in the treatment of central precocious puberty

AU - Lee, Peter A.

AU - Page, John G.

PY - 1989/2

Y1 - 1989/2

N2 - Leuprolide acetate (d-Leu6 des-Gly-NH210, Pro-ethylamide9), a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone, was used to treat 62 children with central precocious puberty. Sex steroid levels (testosterone in boys and estradiol in girls) were suppressed during treatment lasting from 3.5 to 24.9 months. Basal follicle-stimulating hormone values and both luteinizing hormone and follicle-stimulating hormone peak responses to stimulation by luteinizing hormone releasing hormone were also suppressed, atthough basal luteinizing hormone values did not differ. Linear growth rate and the rate of bone age advancement decreased during leuprolide therapy. Side effects were minimal. The long-term safety of this treatment has not yet been established; however, leuprolide appears to be an effective long-term therapy for central precocious puberty.

AB - Leuprolide acetate (d-Leu6 des-Gly-NH210, Pro-ethylamide9), a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone, was used to treat 62 children with central precocious puberty. Sex steroid levels (testosterone in boys and estradiol in girls) were suppressed during treatment lasting from 3.5 to 24.9 months. Basal follicle-stimulating hormone values and both luteinizing hormone and follicle-stimulating hormone peak responses to stimulation by luteinizing hormone releasing hormone were also suppressed, atthough basal luteinizing hormone values did not differ. Linear growth rate and the rate of bone age advancement decreased during leuprolide therapy. Side effects were minimal. The long-term safety of this treatment has not yet been established; however, leuprolide appears to be an effective long-term therapy for central precocious puberty.

UR - http://www.scopus.com/inward/record.url?scp=0024580205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024580205&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(89)80806-6

DO - 10.1016/S0022-3476(89)80806-6

M3 - Article

C2 - 2492599

AN - SCOPUS:0024580205

VL - 114

SP - 321

EP - 324

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 2

ER -